Magnetic resonance imaging (MRI) and diseases of the liver and biliary tract. Part 1. Basic principles, MRI in the assessment of diffuse and focal hepatic disease
Ga. Macdonald et Aj. Peduto, Magnetic resonance imaging (MRI) and diseases of the liver and biliary tract. Part 1. Basic principles, MRI in the assessment of diffuse and focal hepatic disease, J GASTR HEP, 15(9), 2000, pp. 980-991
Magnetic resonance imaging (MRI) relies on the physical properties of unpai
red protons in tissues to generate images. Unpaired protons behave like tin
y bar magnets and will align themselves in a magnetic field. Radiofrequency
pulses will excite these aligned protons to higher energy states. As they
return to their original state, they will release this energy as radio wave
s. The frequency of the radio waves depends on the local magnetic field and
by varying this over a subject, it is possible to build the images we are
familiar with. In general, MRI has not been sufficiently sensitive or speci
fic in the assessment of diffuse liver disease for clinical use. However, b
ecause of the specific characteristics of fat and iron, it may be useful in
the assessment of hepatic steatosis and iron overload. Magnetic resonance
imaging is useful in the assessment of focal liver disease, particularly in
conjunction with contrast agents. Haemangiomas have a characteristic brigh
t appearance on T-2 weighted images because of the slow flowing blood in di
lated sinusoids. Focal nodular hyperplasia (FNH) has a homogenous appearanc
e, and enhances early in the arterial phase after gadolinium injection, whi
le the central scar typically enhances late. Hepatic adenomas have a more h
eterogenous appearance and also enhance in the arterial phase, but less bri
skly than FNH. Hepatocellular carcinoma is similar to an adenoma, but typic
ally occurs in a cirrhotic liver and has earlier washout of contrast. The a
ppearance of metastases depends on the underlying primary malignancy. Overa
ll, MRI appears more sensitive and specific than computed tomography with c
ontrast for the detection and evaluation of malignant lesions. (C) 2000 Bla
ckwell Science Asia Pty Ltd.